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Abstract  
Objective: To determine whether short-term adherence to the Mediterranean Diet (MD) is 
associated with improved physiological function.   
Research Methods and Procedures: This was a single-centre, cohort pilot study.  Twenty-
four healthy, sedentary younger (18-35 years) and older (55-75 years) adults took part.  
Participants were advised and supported to follow the Mediterranean diet for 4 weeks. We 
took baseline and post-intervention measurements of weight, height, waist and hip 
circumference, blood pressure, heart rate, as well as  microvascular physiological 
assessments using laser Doppler Fluximetry (LDF) at rest as well as transcutaneous oxygen 
pressure (TcPO2) during a sub-maximal exercise assessment.   
Results: We identified statistically-significant improvements in axon-mediated microvascular 
vasodilation (2.24 (±0.56) to 3.14 (±0.84), P =0.03) and endothelial-mediated NO synthesis 
(2.59 (±0.67) to 3.32 (±0.87), P =0.022) in the younger group.  Despite the intervention not 
including an exercise element, the rate of perceived exertion was reduced in both groups 
(p<0.001), after following the MD for a month.  
Conclusions: Improvements in physiological function were observed following a short-term 
dietary intervention based on the MD in a younger population. These were not matched in a 
senior group. Our findings suggest that different durations should be applied when 
designing dietary interventions in different age-groups, with expectations in physiological 
improvements differing. 
 
Keywords: Mediterranean diet, LDF, Oxygen tension, cardiovascular disease, blood pressure.  
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Introduction  
Our health is determined by many different factors (e.g., genetical, environmental and 
lifestyle-related). Nutrition is a major, modifiable factor which contributes to our health and 
disease risk. The risk of developing cardiovascular disease (CVD) increases with age, but 
approximately 50% of the adult population and 30% of children are considered at high risk 
of developing CVD [1]. Additionally, events such as the menopause (which causes a decline 
in oestrogen, which has detrimental effects on the cardiovascular system), increases the risk 
of developing CVD in post-menopausal women [2]. CVD affects more than 7 million people 
in the UK, and the cost of managing cardiovascular diseases in the UK is more than £28 
billion per year [3]. Thus, developing new methods of reducing the burden of CVD could 
have the potential to vastly increase the quality of life for many people and reduce 
healthcare costs.   
Fortunately, certain risk factors – such as our diet - are modifiable: With saturated fat and 
salt intake being the two major dietary CVD risk factors [1], it is important to consume diets 
that use less such content. The Mediterranean diet (MD) is based on increased consumption 
of olive oil, fruit, vegetables and salad, fish, legumes, wholegrain foods, moderate 
consumption of wine and limited consumption of red and processed meat, confectionary 
and dairy products [4]. Therefore, the MD contains low levels of saturated fat, salt and free-
sugar, and high unsaturated fat and fibre. This dietary composition is associated with 
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decreased build-up of fatty deposits in blood vessels [5], reducing the risk for CVD and 
associated health conditions (e.g., stroke, heart attack and atherosclerosis) [6, 7].  
Endothelial dysfunction is a major risk factor for the development of CVD and hypertension 
[3], characterised by diminished nitric oxide supply and a lack of arterial vasodilation [8] and 
strongly affected by age [7]. Endothelial dysfunction is known to be reversible; a healthier 
diet such as MD can potentially reduce  the dietary risk factors, enhancing endothelial 
function [9].   
Research shows that long-term adherence to the MD reduces the development of 
cardiovascular disease. For example, recent studies suggest a 9% reduction in overall 
mortality [10], and a reduction of cardiovascular risk factors in the elderly population in 
those following the MD, either on its own [11] or in combination with exercise [12].   
Although the benefits of MD adherence are undeniable, there are certain elements that 
need to be explored further: for example it is unknown what is the optimal duration of an 
MD regime and at which point do the cardiovascular benefits can be firstly observed. It is 
also unknown whether benefits are similar between different age groups. Such knowledge 
could help to provide a clearer structure for health practitioners to develop interventions at 
specific population- or age-groups,  providing more effective interventions.   
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We therefore conducted a study, aiming to determine the short-term effects of the MD on 
the human physiology and compare the differences in physiological effects between senior 
and younger age groups.   
We hypothesised that both groups will show improvements in microvascular, physiological 
function after the MD intervention, with effects being greater in the senior group.  
Methods  
Ethical Approval  
This study was approved by the Sheffield Hallam University Ethics Review Committee. All 
participants provided written consent to take part in the study.   
Study Design  
This was a single-centre, cohort study. Baseline measurements of physiological function 
were taken in an initial laboratory session. The subjects then followed the MD for one 
month, after which time, all measurements were repeated.   
Participants  
Twelve participants were aged 18-35, and twelve were aged 55-75. All participants were 
healthy, sedentary and not taking any form of medication that may influence cardiovascular 
function. Volunteers were recruited via posters, emails to staff and students of the 
University of Sheffield and Sheffield Hallam University, and word of mouth in Sheffield, 
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United Kingdom. All participants were screened to ensure they did not already follow the 
Mediterranean diet (e.g., consuming olive oil, fruit, vegetables and salad, ﬁsh, legumes, 
poultry meat, wholegrain foods and wine), using MEDAS, a validated Mediterranean diet 
adherence questionnaire [13]. Individuals who scored more than 6 MEDAS were considered 
to already be consuming significant elements of the Mediterranean diet on a regular basis, 
therefore they were excluded. Participants’ physical activity levels were assessed (in the 
form of Metabolic Equivalent of Task (MET)-minutes) via an International Physical Activity 
Questionnaire (IPAQ) [14] to ensure they met the sedentary requirements.   
Exclusion criteria were an active lifestyle (i.e. not sedentary defined as undertaking more 
than 60 min of structured or planned physical activity per week), habitual adherence to the 
MD, any chronic disease that could affect vascular function (such as diabetes, CVD and 
hypertension), pregnancy and smoking.  
Protocol  
Eligible participants were invited to the University of Sheffield Hallam Centre of Health and 
Wellbeing on two occasions. Participants had their height, weight, hip and waist 
circumference measured and recorded, and from this, BMI was calculated using the 
formula:  
BMI= weight (kg)/ (height (m)2).  
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MEDAS was used to measure the current adherence of participants to the MD, both prior to 
starting and at the end of the intervention. Participants also completed two 3-day estimated 
food diaries [15] one prior to beginning the diet, and one during the last week of the diet, to 
determine their adherence to the MD.  
Participants were instructed to follow the Mediterranean Diet for 4 weeks, or until their 
second appointment, depending on their availability. They were given a food "starter" pack, 
providing them with staples such as brown rice, brown pasta, lentils, olive oil, nuts, chopped 
tomatoes and tomato puree. Participants were also given instructions on how to adapt their 
current diet to the MD. We considered making swaps (such as swapping white pasta and 
rice to wholegrain varieties), to be more achievable than a complete diet overhaul. We also 
provided participants with an information booklet, guidelines on what constitutes the MD 
and a recipe booklet. A Facebook group was set up to support participants and answer any 
questions. This group provided support by regularly adding recipes and tips, and 
encouraging participants to share any experiences or problems, to create a supportive 
community-feel to the group, allowing participants to support each other throughout the 
diet.   
Transcutaneous oxygen pressure (TcPO2) and sub-maximal exercise tests  
A discontinuous sub-maximal test involving 4 rounds of exercise was completed to measure 
the participants’ transcutaneous oxygen pressure (TcPO2). Measurements were taken by 
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attaching the participants to a probe. The probe was heated to 44.5°C, to non-invasively 
cause maximal dilation of the skin capillaries. The TcPO2 values were measured and 
recorded by the sensor. Measurements were taken by the TINA TCM400 TcPO2 device, 
(Radiometer, Copenhagen, Denmark). The electrode was placed on the participants’ back, 
below the right scapula. TcPO2 readings were taken directly from the raw oxygen tension 
values, measured by the device.   
The participants were characterised as being either "healthy" or "diseased". In healthy 
participants, their initial TcPO2 readings increased during exercise, whereas diseased 
participants showed a decline in initial TcPO2 measurements during exercise [16].   
Participants cycled for 20 minutes, with a 2-minute break after each 5 minutes of exercise.  
The participants maintained a speed of 80RPM, and after each 5-minute period, an extra  
0.2kg of resistance was added to the ergometer, beginning on 1kg of resistance.  
The participants were encouraged to reach their maximum exertion limit before stopping, 
but  
could stop before the end of the test if they needed to.   
Self-perceived exertion  
During the sub-maximal exercise test, we measured the rate of perceived exertion (RPE) of 
participants at one-minute intervals whilst they were cycling [17]. The RPE scale counts from 
6-20, with 6 representing no exertion and 20 representing maximal exertion [18]. The RPE 
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scale is approximately linked to heart rate (with 6 corresponding to 60 beats/minute, and 20 
corresponding to 200 beats/minute [18].  Finally, RPE values were explained and 
participants were trained in giving them, prior to assessments.  
Laser Doppler Flowmetry (LDF)  
Laser Doppler Flowmetry (LDF) combined with local heating of the skin was used to 
determine cutaneous microvascular responsiveness providing a simple approach for 
examining the microvascular and endothelial function [19]. The tests were conducted in a 
temperature-controlled room, with an ambient temperature of 22 –24°C, as previously 
described by our group [20]. A site on the upper right forearm was chosen avoiding visible 
vein, body hair and damaged or irritated skin. This site was sterilised, then the LDF probe 
was attached to the skin. Local thermal hyperaemia was induced using a heating disc (Model 
455, Perimed AB) connected to a heating unit (Model 5020, Perimed AB) and LDF signals 
were recorded using PeriSoft for Windows 9.0 software (PSW 9.0). Throughout the LDF, the 
resting HR and BP (systolic and diastolic) were recorded from left arm at baseline and at 5-
min intervals using a patient monitoring device (Dinamap Dash 2500, GE Healthcare; USA). 
Baseline skin blood flow data was recorded for five minutes with the local heating disc 
temperature set at 32°C. Then, the temperature of the probe was increased by 1°C every 
10s until 42°C was reached to induce rapid local heating. This was maintained for 25 
minutes. After this,the temperature was quickly increased to 44°C for the final 10 minutes to 
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obtain maximal vasodilatation, which completed the test. Regions of the response were 
then recorded (Table 1). The LDF values divided by the corresponding mean arterial pressure 
to give the cutaneous vascular conductance (CVC) in APU/mm Hg. The mean arterial 
pressure was calculated from systolic and diastolic blood pressure. The data presented as 
raw CVC and CVC normalised to maximum (%CVCmax = [(CVC / maximum CVC) x 100]). The 
resting HR and BP of participants were calculated from the average of measured HR and BP 
throughout the LDF.  
Statistical analysis  
As this was a pilot study, no formal sample size was calculated and the “sample size of 12 
per group” was followed [21]. 
 Paired t-tests were undertaken to compare the effects of the MD on BMI, waist and hip 
circumference, TcPO2,  RPE, CVC, %CVC Max and MD score between the younger and senior 
groups at the same time-point. The baseline and post-intervention data were compared, 
also comparing the differences between the senior and younger group. The data recorded 
during the initial laboratory assessment, prior to the intervention, was used as the baseline 
measurements. Statistical analysis was performed using SPSS. Statistical significance for the 
test was set at P≤ 0.05. Values were presented as mean (± SD).  
Results  
Participant Characteristics  
Twelve participants aged 18-35 were eligible to take part in the study, making up the 
younger group. All participants completed all  study assessments (Table 2).  An equal 
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number of older (e.g., 55-75 years of age) participants have completed all study assessments 
(Table 2).  
Anthropometric measures  
No significant differences in BMI, waist circumference, hip circumference, heart rate or 
resting systolic or diastolic blood pressure from pre-intervention to post-intervention 
measurements in either the younger or the senior group (Table 2). There was no significant 
difference between groups in hip circumference, heart rate or diastolic blood pressure. 
However, there was a significant difference between groups in BMI, waist to hip ratio, waist 
circumference, and systolic blood pressure, with significantly lower values in the younger 
group for each measurement.   
Blood pressure, BMI and weight   
There was no significant difference between BMI post-intervention, compared to baseline, 
in either the younger group or the senior group. There was a significant difference between 
the BMI of the younger and senior groups at baseline (p<0.05), and after the intervention 
(p<0.05).   
There was also no significant difference between the younger group’s systolic or diastolic 
blood pressure. Likewise, the senior group showed no statistically significant difference 
between the baseline and end of intervention in systolic or diastolic blood pressure.  
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There was a statistically-significant difference between the pre-intervention values for 
systolic blood pressure between groups (p<0.001). However, there was no significant 
difference between the baseline values for diastolic blood pressure between the younger 
and senior groups.   
Side effects  
No participants withdrew from the study and  no side effects were reported during the 
study period.   
Compliance  
Mean MD score increased significantly in both the younger group (p<0.001) and the senior 
group (p<0.001) (Table 3). There was no significant difference in MD score between groups 
prior to the intervention, but there was a significant difference between the senior and 
younger groups MD scores at the end of the intervention, with the senior group reporting a 
higher MD score at the end of the intervention (p<0.05).   
Compliance was also calculated through 3-day estimated diet records completed by the 
participants. The main findings from the records are summarised below (Table 3), in regards 
to energy, carbohydrate, fibre, protein, total fat, saturated fat, monounsaturated fat, 
polyunsaturated fat, fruit and vegetables, olive oil. Compliance to the MD was excellent, 
with statistically significant increases in intake of fruit and vegetables, fibre and olive oil, and 
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significant decreases in saturated fat. There was however, no significant change in 
monounsaturated fat or polyunsaturated fat intake.  
Cutaneous vascular conductance (CVC)  
Baseline   
Raw CVC  
There was no statistical difference between the groups for Raw CVC baseline records at any 
visit. Raw CVC baseline readings within the groups improved but there were not significant 
in either of the two groups (Table 4).   
%CVC Max  
There was no statistical difference between the groups or changes to %CVC Max baseline 
records in either group at any time. The post-intervention %CVC Max values were 
diminished for younger groups, but elevated for senior groups (Table 4).  
Initial Peak  
Raw CVC  
There was statistically-significant improvement for Raw CVC at initial peak within our 
younger group (2.24 (±0.56) to 3.14 (±0.84), P =0.03). The senior group’s Raw CVC values 
were increased but not statistically significant. Additionally, no significant difference 
between groups was noticed at the beginning of the intervention for Raw CVC; nevertheless, 
there was a statistically significant difference between groups at the end of the intervention 
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with the senior group indicating a lower value (3.14 (±0.84) vs 2.52 (±0.59), P =0.046) (Table 
4). 
%CVC Max  
No statistical differences between the groups or changes to %CVC Max at the initial peak 
readings in either group at any time was observed (Table 4).  
Plateau  
Raw CVC  
Similarly to Raw CVC at initial peak, only the younger group had a statistically significant 
improvement for Raw CVC at plateau (e.g., 2.59 (±0.67) to 3.32 (±0.87), P =0.02). The 
increase in the senior group values did not reach statistical significance, and neither were 
the differences between groups at both visits (Table 4).  
%CVC Max  
There were no statistical differences between the groups or changes to %CVC Max plateau 
records in either group, at any time (Table 4).   
Oxygen Tension  
Baseline  
There were no statistically-significant differences between the TcPO2 values for the younger 
or senior group between the pre- and post-intervention measurements, either within- or 
between-groups.   
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ΔTcPo2  
There was also no significant difference in ΔTcPo2 for either group, between the two study 
visits. There was no significant difference between groups at either the pre- or post-
intervention measurements.   
TcPO2max  
There was no significant difference between the TcPO2max pre- and post-intervention in 
the young group or the senior group. There was also no significant difference between the 
groups, either pre- or post-intervention.   
ΔTcPo2max  
There was no significant difference in ΔTcPo2max in either group between visits, or between 
groups at either visit.   
TcPO2 profiles  
Following the categorisation by Ouedraogo and colleagues [16], we characterised 
participants as either   "healthy" or "diseased", according to their TcPO2 profiles. All 
participants in both groups were found to be “healthy” both before and after the 
intervention.  
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Rate of Perceived Exertion (RPE) and Heart Rate  
There was a statistically-significant reduction between the RPE from pre- to post-
intervention in both the younger and senior groups (Table 5). No differences were observed 
between groups at baseline, however, a statistically-significant difference was noted post-
intervention (Table 5).  
No statistically-significant differences were observed either between- or within-groups at 
any stage in regards to heart rate (Table 5).  
However, peak heart rate during exercise was significantly higher in the younger group in 
comparison to the senior group at all times (e.g., visit 1 (119 vs 96, p<0.05) and visit 2 (117 
vs 97, p<0.05) (Table 5).   
Discussion  
Our study participants reported enjoying their month following the MD  anecdotally feeling 
healthier in themselves, which is in line with previous research by our group [22].  The 3-
2day food diary reported during the intervention suggested excellent adherence to the diet 
in terms of saturated fat, fibre, fruit and vegetables, and olive oil intake. This suggests that 
the MD is an achievable diet to maintain in the long-term, which is an important pre-
requisite of any successful public health initiative.  
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Blood pressure, in-exercise heart rate and RPE 
There was no statistically significant change in systolic or diastolic blood pressure in either 
the younger or the senior group. However, there was a reduction in diastolic blood pressure 
in both groups, although significance was not reached. These findings are consistent with 
other studies, which found that MD [23] or MD-inspired diets [24] caused a reduction in 
blood pressure. These results suggest that the MD intervention could be beneficial in 
reducing hypertension risk, and in turn, risk of developing CVD.  However, some participants 
anecdotally reported "white coat syndrome" when their blood pressure was measured, 
which may suggest that any improvements in blood pressure caused by the MD were 
outweighed by increases in blood pressure due to anxiety.  This might have been greater in 
our older female participants, as higher age and the female gender are two known “white 
coat syndrome” parameters [25]. 
Our study also notes a significant reduction in RPE, between visits, in both groups, although 
no such change was observed with exercising heart rate. The significance of this finding is 
unknown, although Kakarot and Müller suggest that RPE (a psychological estimation of 
exertion) is a better estimation of exertion than heart rate (a physiological estimation of 
exertion), as RPE alters in strong positive correlation with current exertion, whereas heart 
rate continues to increase after exertion has decreased [26]. Considering that we didn't 
18  
  
offer exercise sessions as part of our intervention, it could be that the MD triggered 
additional lifestyle changes, which affected perceived exertion as well. 
 
Cutaneous microvascular function  
Our findings were consistent with previous studies interpreting the effects of sedentary 
aging on cutaneous microvascular function. Similar to Tew et al. [27], lower raw CVC of pre- 
and post- intervention during the initial peak and plateau stages were observed on the older 
participants, implying age-related vasodilation impairment in response to local skin heating. 
This is important because age-related reduction in microvascular function is associated with 
increased risk of CVD [28].  
In the present study, statistically-significant improvements were observed in Raw CVC at 
initial peak and plateau stages for younger participants, suggesting that following the MD 
leads to improvements in axon-mediated vasodilation during the initial peak and 
endothelial-mediated NO synthesis during the plateau. Decreasing axon-mediated 
vasodilation suggests microcirculatory dysfunction [29] and thus, increased risk of 
cardiovascular events [9]. Because the plateau stage is largely mediated by NO, this reveals 
that the NO levels in the younger group was statistically-significant increased. It is well 
established that maintaining NO at adequate levels can reduce risk of CVD as reduced bio-
availability of NO leads to a loss of cardio-protective actions and may even elevate the 
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progression of CVD [30]. This is consistent with previous literature in which an increase in 
endothelial function was observed following the MD [2, 12, 31]. This suggests that diet is a 
potential mechanism to improve endothelial function in the younger population. However, 
although endothelial function and axon-mediated vasodilation of older participants slightly 
increased after the MD, they were not statistically-significant, which is consistent with other 
studies [32]. 
In overall, although higher mean changes were found in senior group,  statistically-
significant improvements were only observed in the younger participants. This suggests that 
the younger population may be more responsive to the MD, and older individuals might 
have dampened responsiveness due to other age-related factors, (e.g., hormonal changes, 
lifestyle etc.) during a short-term implementation period [28, 33]. Future research may 
concentrate on comparing implementation periods for the senior population in conjunction 
with other lifestyle initiatives (e.g., smoking cessation, exercise) and assess the optimal 
duration after which significant improvements are detected.  
Transcutaneous oxygen pressure (TcPO2)  
It is well established that older adults are more susceptible to a lower oxygen perfusion than 
younger people, as blood vessels narrow, and arteries reduce elasticity due to increased risk 
of plaques causing blockages as we age [5]. This reduction in blood vessel efficacy may 
eventually be enough to cause reduced blood flow, causing hypertension. During 
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submaximal exercise, e.g. climbing stairs, carrying heavy shopping, etc. oxygen demand is 
high. Therefore, if there is a problem with TcPO2, it will become apparent during 
submaximal exercise.  No measure of TcPO2  changed significantly between pre-
intervention and post-intervention measurements in either the younger or the senior group. 
This suggests that the MD as a short-term intervention may not be beneficial for improving 
oxygen tension, which means that cardiovascular risk remained the same before and after 
the MD in the study. However, in the long-term, dietary change (alongside weight loss) has 
been shown to be successful in improving microvascular function in overweight adults, 
similar to ours [34]. This research however, found that the benefits of the MD are greater 
for individuals who are less healthy at baseline, and also that exercise is also beneficial to 
improving microvascular function [35]. This suggests that a 4-week MD intervention may not 
be long enough to improve oxygen perfusion, and ultimately reducing an individual’s risk of 
CVD, as CVD develops over a life-time.   
Experimental considerations and limitations 
All  study participants were in general good health:  this may mean that findings may be 
different in clinical or unhealthy populations. It is however, a positive first step for further 
research aiming at the general population.  We also chose to use a 3-day diet diary instead 
of the “gold standard” -e.g., the 7-day weight food diary. Our choice however, was made in 
order to reduce participants’ burden  and decrease the likelihood of drop-outs.   
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We acknowledge that additional anthropometric measurements/assessments could have 
been completed, however, as the focus of the study was on vascular function and these 
tests tend to be lengthy we decided against adding further tests, to limit patient burden. 
Finally, although participants were asked to avoid caffeine intake for 3h before the 
assessments, it was difficult to factually control whether this was actually observed or not..   
Conclusions  
In overall, we found evidence that a short-term intervention based on MD offered 
physiological benefits in a younger population. In contrast, no significant improvements 
were observed in a senior, healthy population, which was against to our original hypothesis.  
Therefore, and having in mind that an 8-week MD-based intervention improves 
microvascular function in senior healthy groups [12], further work needs to be undertaken 
to establish the optimum point at which physiological benefits can be observed by 
consuming the MD, as well as whether this can be achieved on its own or in combination of 
other intervention elements (e.g., exercise). Considering the known long-term benefits of 
the MD, it would be interesting to identify a minimum duration at which adherence to the 
MD results in benefits to cardiovascular physiology. In the long-term, the MD as a strategy 
to reduce the burden of CVD could have huge social and economic benefits to the NHS and 
social care system, as well as for individuals. Therefore, further research into a shorter-term 
MD intervention could be beneficial – as our findings suggest. There is a crucial need for 
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research into CVD reduction strategies, and the need for these findings to be promoted in 
clear public health messages.   
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Table 1   
Laser Doppler Flowmetry regions of recorded responses. 
Response  Time  
Baseline  The  arithmetic mean of the last 2 min of the first 5 min. 
Initial peak  The arithmetic mean of the highest consecutive 30-s period within 
the distinct initial hyperaemic response. 
Plateau  The arithmetic mean of the last 2 min of heating at 42 °C 
Maximum  The arithmetic mean of the last 2 min of heating at 44 °C. 
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Table 2 
Participant characteristics for the younger and older groups. 
 Group A (younger group) Group B (older group) 
 Visit 1 Visit 2 Visit 1 Visit 2 
Gender 2 males, 10 females 4 males, 8 females 
Age (years) 25 (±2.57) 59 (±3.97)# 
Height (cm) 1.70 (±0.1) 1.66 (±0.1) 
Weight (kg) 66.9 (±12.8) 67.1 (±13.0) 75.3 (±14.9) 74.6 (±15.2) 
BMI (kg/m2) 23.1 (±3.2) 23.2 (±3.2) 27.3 (±4.5)# 27.1 (±4.7)# 
Waist 
circumference (cm) 
73.8 (±10.4) 73.6 (±9.7) 90.0 (±12.3)# 88.8 (±13.6)# 
Hip circumference 
(cm) 
97.5 (±7.8) 99.1 (±7.2) 103.8 (±8.3) 102.4 (±9.2) 
Resting HR  69 (± 9.6) 72 (±13.2) 61 (± 7.6) 62 (±8.1)# 
Waist to hip ratio 0.76 (±0.04) 0.74 (±0.05) 0.87(±0.04)# 0.87(±0.05)# 
Resting BP (mmHg) 108 (±8.5) 109 (±6.7) 126 (±10.3)# 126 (±13.6)# 
Resting diastolic BP 
(mmHg) 
68 (±6.8) 68 (±4.9) 76 (±10.4)# 77 (±10.7)# 
#P≤0.05 between groups (at the same time-point). 
HR: heart rate; BP: blood pressure. 
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Table 3.  
Compliance to MD calculated from the 3-day diet diaries. 
*P≤0.05 between visits (within groups). #P≤0.05 between groups (at the same time-point). 
§Serving based on 13g estimate (1 tablespoon of olive oil). §§Serving based on 80g estimate 
(1 portion of 5-a-day).   
CHO: carbohydrates; MUFA: monounsaturated fatty acid; PUFA: Polyunsaturated fatty acid.  
 
 
 
 Visit 1 Visit 2 Mean 
change 
Visit 1 Visit 2 Mean 
change 
MD score  4 (±1.5)*  11 (±1.1)  +7  4 (±0.9)*  12 (±1.0)#  +8  
Energy/nutrient              
Total energy 
(kcal/day)  
2088  
(±590)  
1868  
(±517)  
-220  
1821  
(±500)  
1533  
(±342)  
-288  
CHO (g/day)  221 (±54)  199 (±53)  -22  190 (±70)  
145  
(±41)#*  
-45  
Fibre (g/day)  20.8  
(±5.8)  
26.8  
(±6.7)*  
+6.0  18.5  
(±6.5)  
22.7 
(±6.8)*  
+4.2  
Protein (g/day)  83.0  
(±36.5)  
82.3  
(±31.3)  
-0.7  63.8  
(±21.5)  
68.8  
(±16.4)  
+5.0  
Fat (g/day)  88 (±33)  74 (±29)*  -14  79 (±29)  66 (±19)  -13  
Saturated fat 
(g/day)  
30.7  
(±13.1)  
20.0 
(±11.7)*  
-11  31.3  
(±14.7)  
18.1 
(±5.7)*  
-13.2  
MUFA (g/day)  
30.3  
(±12.4)  
32.0  
(±11.5)  
+1.7  
28.6  
(±12.0)  
29.3  
(±7.9)  
+0.7  
PUFA (g/day)  
13.4  
(±5.4)  
14.9  
(±6.4)  
+1.5  
12.1  
(±4.4)  
11.9  
(±6.4)  
-0.2  
Food items              
Olive oil  
(serving/day)§  
0.2 (±0.3)  1.8 (±1.2)*  +1.6  0.1 (±0.5)  1.7 (±1.2)*  +1.6  
Fruit and 
vegetable 
(serving/day)§§  
3.6 (±1.0)  5.5 (±1.7)*  +1.9  4.7 (±4.3)  7.7 (±3.5)*  +3.0  
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 Table 4 
Cutaneous vascular conductance data for the younger and senior groups.  
 
  
  
Group A (younger group)  Group B (senior group)  
Raw CVC  %CVC Max  Raw CVC  %CVC Max  
Baseline  
Visit 1 (pre)  
  
0.19 (±0.09)  
  
6.64 (±3.65)  
  
0.23 (±0.12)  
  
8.06 (±4.84)  
Visit 2 (post)  0.24 (±0.13)  6.03 (±4.25)  0.32 (±0.22)  10.4 (±11.4)  
Change (post-pre)  0.05 (±0.15)  -0.62 (±5.66)  0.08 (±0.25)  2.32 (±11.4)  
Initial peak  
Visit 1 (pre)  
  
2.24 (±0.56)  
  
77.9 (±20.4)  
  
2.09 (±0.57)  
  
72.1 (±15.8)  
Visit 2 (post)  3.14 (±0.84)*  74.6 (±16.0)  2.52 (±0.59)#  74.3 (±16.5)  
Change (post-pre)  0.90 (±0.83)  -3.28 (±11.3)  0.43 (±0.86)  2.18 (±24.4)  
Plateau  
Visit 1 (pre)  
  
2.59 (±0.67)  
  
89.5 (±21.1)  
  
2.45 (±0.66)  
  
84.8 (±18.3)  
Visit 2 (post)  3.32 (±0.87)*  78.4 (±11.7)  2.98 (±1.04)  84.2 (±10.7)  
Change (post-pre)  0.73 (±0.95)  -11.1 (±30.0)  0.53 (±1.11)  -0.60 (±20.0)  
*P≤0.05 between visits (within groups).  #P≤0.05 between groups (at the same time-point).  
CVC: cutaneous vascular conductance 
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Table 5.  
Sub-maximal exercise data comparing physiological function between visits and  between 
groups.   
  Younger  
group  
P value   
(between   
visits)   
Senior 
group  
P value  
(between  
visits)  
P value  
(between 
groups)  
Baseline TcPO2 (mm Hg)  
Visit 1  
  
Visit 2  
  
73.1 (20.1)  
  
70.8 (12.4)  
  
  
0.788  
  
66.4 (14.7)  
  
66.7 (7.0)  
  
  
0.965  
  
0.363  
  
0.320  
TcPO2max (mm Hg)  
Visit 1   
  
87.6 (27.0)  
  
  
  
0.767  
  
77.8 (13.5)  
  
  
  
0.744  
  
0.271  
  
Visit 2  84.6 (12.1)  
  
 79.4 (7.5)   0.220  
ΔTcPo2 (mm Hg)  
Visit 1  
  
Visit 2  
  
  
7.7 (3.8)  
  
9.1 (4.6)  
  
  
0.427  
   
6.2 (4.5)  
   
7.1 (9.6)  
  
  
  
0.801  
  
0.381  
  
0.518  
ΔTcPo2max (mm Hg)  
Visit 1  
  
Visit2  
  
  
14.5 (9.1)  
  
13.8 (5.3)  
  
  
0.736  
  
11.3 (4.3)  
  
12.8 (7.9)  
  
  
0.569  
  
0.287  
  
0.699  
Mean exercise HR 
(beats/min) Visit 1  
  
Visit 2  
  
119 (16)  
  
117 (10)  
  
  
0.766  
  
96 (20)  
  
97 (20)  
  
  
0.674  
  
0.013†  
  
0.047†  
RPE (exertion)  
Visit 1  
  
Visit 2  
  
12.3 (1.9)  
  
11.8 (1.6)  
  
  
<0.001**  
  
  
11.8 (1.6)  
  
10.6 (1.6)  
  
  
<0.001**  
  
0.181  
  
0.018†  
TPcO2 profile 
characterisation Visit 1  
Visit 2  
  
12 healthy  
  
12 healthy  
  
1.0  
  
1.0  
  
12 healthy  
  
12 healthy  
  
1.0  
  
1.0  
  
1.0  
  
1.0  
*p<0.05 between visits (within groups), **p<0.001 between visits (within groups), † p<0.05 
between groups (at the same visit).  
TPcO2: Transcutaneous oxygen pressure. 
